Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Implanet S.A.

IMPZYPNK
Healthcare
Medical - Devices
$0.08
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Implanet S.A. Fundamental Analysis

Implanet S.A. (IMPZY) shows moderate financial fundamentals with a PE ratio of -48.02, profit margin of -33.88%, and ROE of 13.22%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-2.96

Areas of Concern

Operating Margin-32.59%
Cash Position0.22%
Current Ratio0.72
We analyze IMPZY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 70.3/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B
70.3/100

We analyze IMPZY's fundamental strength across five key dimensions:

Efficiency Score

Weak

IMPZY struggles to generate sufficient returns from assets.

ROA > 10%
-25.46%

Valuation Score

Excellent

IMPZY trades at attractive valuation levels.

PE < 25
-48.02
PEG Ratio < 2
-2.96

Growth Score

Weak

IMPZY faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

IMPZY shows balanced financial health with some risks.

Debt/Equity < 1
-4.49
Current Ratio > 1
0.72

Profitability Score

Weak

IMPZY struggles to sustain strong margins.

ROE > 15%
13.22%
Net Margin ≥ 15%
-33.88%
Positive Free Cash Flow
No

Key Financial Metrics

Is IMPZY Expensive or Cheap?

P/E Ratio

IMPZY trades at -48.02 times earnings. This suggests potential undervaluation.

-48.02

PEG Ratio

When adjusting for growth, IMPZY's PEG of -2.96 indicates potential undervaluation.

-2.96

Price to Book

The market values Implanet S.A. at -148.17 times its book value. This may indicate undervaluation.

-148.17

EV/EBITDA

Enterprise value stands at -37.33 times EBITDA. This is generally considered low.

-37.33

How Well Does IMPZY Make Money?

Net Profit Margin

For every $100 in sales, Implanet S.A. keeps $-33.88 as profit after all expenses.

-33.88%

Operating Margin

Core operations generate -32.59 in profit for every $100 in revenue, before interest and taxes.

-32.59%

ROE

Management delivers $13.22 in profit for every $100 of shareholder equity.

13.22%

ROA

Implanet S.A. generates $-25.46 in profit for every $100 in assets, demonstrating efficient asset deployment.

-25.46%

Following the Money - Real Cash Generation

Operating Cash Flow

Implanet S.A. generates limited operating cash flow of $-240.73K, signaling weaker underlying cash strength.

$-240.73K

Free Cash Flow

Implanet S.A. generates weak or negative free cash flow of $-1.06M, restricting financial flexibility.

$-1.06M

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

IMPZY converts -0.70% of its market value into free cash.

-0.70%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-48.02

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-2.96

vs 25 benchmark

P/B Ratio

Price to book value ratio

-148.17

vs 25 benchmark

P/S Ratio

Price to sales ratio

14.03

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-4.49

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.72

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

13.22

vs 25 benchmark

ROA

Return on assets percentage

-0.25

vs 25 benchmark

ROCE

Return on capital employed

-64.28

vs 25 benchmark

How IMPZY Stacks Against Its Sector Peers

MetricIMPZY ValueSector AveragePerformance
P/E Ratio-48.0227.88 Better (Cheaper)
ROE1321.52%687.00% Excellent
Net Margin-33.88%-32409.00% (disorted) Weak
Debt/Equity-4.490.34 Strong (Low Leverage)
Current Ratio0.722775.21 Weak Liquidity
ROA-25.46%-9672.00% (disorted) Weak

IMPZY outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Implanet S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ